John Brendan Doyle - 01 May 2025 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Financial Officer
Signature
/s/ John Brendan Doyle
Issuer symbol
CGTX
Transactions as of
01 May 2025
Net transactions value
-$4,334
Form type
4
Filing time
02 May 2025, 17:53:52 UTC
Previous filing
18 Feb 2025
Next filing
31 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle John Brendan Chief Financial Officer C/O COGNITION THERAPEUTICS, INC., 2500 WESTCHESTER AVE, PURCHASE /s/ John Brendan Doyle 02 May 2025 0001840738

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Tax liability $4,334 -9,692 -2.3% $0.4472 404,710 01 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.